| MAIT cells are activated during human viral infections B Van Wilgenburg, I Scherwitzl, EC Hutchinson, T Leng, A Kurioka, ... Nature communications 7 (1), 11653, 2016 | 472 | 2016 |
| Flying under the radar: the immunobiology of hepatitis C LB Dustin, CM Rice Annu. Rev. Immunol. 25, 71-99, 2007 | 436 | 2007 |
| Cell culture–produced hepatitis C virus does not infect peripheral blood mononuclear cells S Marukian, CT Jones, L Andrus, MJ Evans, KD Ritola, ED Charles, ... Hepatology 48 (6), 1843-1850, 2008 | 279 | 2008 |
| Interferon (IFN)–γ–inducible protein–10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-α2a and ribavirin for chronic … AI Romero, M Lagging, J Westin, AP Dhillon, LB Dustin, JM Pawlotsky, ... The Journal of infectious diseases 194 (7), 895-903, 2006 | 271 | 2006 |
| Hepatitis C virus–induced cryoglobulinemia ED Charles, LB Dustin Kidney international 76 (8), 818-824, 2009 | 267 | 2009 |
| Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner JA McKeating, LQ Zhang, C Logvinoff, M Flint, J Zhang, J Yu, D Butera, ... Journal of virology 78 (16), 8496-8505, 2004 | 243 | 2004 |
| Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C D Butera, S Marukian, AE Iwamaye, E Hembrador, TJ Chambers, ... Blood 106 (4), 1175-1182, 2005 | 228 | 2005 |
| Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1) MJ Fuller, B Callendret, B Zhu, GJ Freeman, DL Hasselschwert, ... Proceedings of the National Academy of Sciences 110 (37), 15001-15006, 2013 | 217 | 2013 |
| Clonal B cells in patients with hepatitis C virus–associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset ED Charles, C Brunetti, S Marukian, KD Ritola, AH Talal, K Marks, ... Blood, The Journal of the American Society of Hematology 117 (20), 5425-5437, 2011 | 207 | 2011 |
| Hepatitis C virus induces interferon‐λ and interferon‐stimulated genes in primary liver cultures S Marukian, L Andrus, TP Sheahan, CT Jones, ED Charles, A Ploss, ... Hepatology 54 (6), 1913-1923, 2011 | 201 | 2011 |
| Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia ED Charles, RM Green, S Marukian, AH Talal, GV Lake-Bakaar, ... Blood, The Journal of the American Society of Hematology 111 (3), 1344-1356, 2008 | 197 | 2008 |
| Efficient replication of genotype 3a and 4a hepatitis C virus replicons in human hepatoma cells M Saeed, TKH Scheel, JM Gottwein, S Marukian, LB Dustin, J Bukh, ... Antimicrobial agents and chemotherapy 56 (10), 5365-5373, 2012 | 144 | 2012 |
| Expression of dominant-negative src-homology domain 2-containing protein tyrosine phosphatase-1 results in increased Syk tyrosine kinase activity and B cell activation LB Dustin, DR Plas, J Wong, YT Hu, C Soto, AC Chan, ML Thomas The Journal of Immunology 162 (5), 2717-2724, 1999 | 136 | 1999 |
| Ly-6C is a marker of memory CD8+ T cells. TL Walunas, DS Bruce, L Dustin, DY Loh, JA Bluestone Journal of immunology (Baltimore, Md.: 1950) 155 (4), 1873-1883, 1995 | 116 | 1995 |
| Quasispecies heterogeneity within the E1/E2 region as a pretreatment variable during pegylated interferon therapy of chronic hepatitis C virus infection TJ Chambers, X Fan, DA Droll, E Hembrador, T Slater, MW Nickells, ... Journal of virology 79 (5), 3071-3083, 2005 | 108 | 2005 |
| Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy LB Dustin, B Bartolini, MR Capobianchi, M Pistello Clinical microbiology and infection 22 (10), 826-832, 2016 | 103 | 2016 |
| Expression of paramyxovirus V proteins promotes replication and spread of hepatitis C virus in cultures of primary human fetal liver cells L Andrus, S Marukian, CT Jones, MT Catanese, TP Sheahan, ... Hepatology 54 (6), 1901-1912, 2011 | 93 | 2011 |
| Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients J Ni, E Hembrador, AM Di Bisceglie, IM Jacobson, AH Talal, D Butera, ... The journal of immunology 170 (6), 3429-3439, 2003 | 93 | 2003 |
| The humoral immune response to HCV: understanding is key to vaccine development SB Cashman, BD Marsden, LB Dustin Frontiers in immunology 5, 117405, 2014 | 87 | 2014 |
| Innate and adaptive immune responses in chronic HCV infection L B Dustin Current drug targets 18 (7), 826-843, 2017 | 78 | 2017 |
